- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05041634
Physical Activity for People With Behavioral Diagnoses
The Physical and Psychosocial Influences of an Exercise and Activity Program on People With Behavioral Diagnoses: A Cohort Study
Study Overview
Detailed Description
Our aims are to 1) test that our intervention that can be measured with high fidelity. 2) determine the feasibility of the intervention including recruitment, procedures, measures, intervention acceptability and resources . 3)We will also test the outcomes of this 14-week fitness and wellness program based at a YMCA Healthy Living Center to gauge the effects of exercise and activity on patients with behavioral diagnoses including bipolar disorder, schizoaffective disorder, and schizophrenia. We also want to explore the influence of participating in such a program on the perceptions of mental illness among rehabilitation sciences students.
Our hypotheses are 1) that a fitness and activity program using physical activity, group discussion, and education delivered in a fitness facility will reduce anxiety and depression and strengthen hope, self-esteem, and improve overall quality of life; and 2) that student perceptions of mental illness will improve after participating in such a fitness and activity program.
Research Questions:
How does a program of exercise and activity influence the physical health of people with behavioural diagnoses as it relates to venous blood plasma measures of haemoglobin, cholesterol, lipids, insulin, glucose, triglycerides, high-density lipoproteins; height, weight, abdominal girth, blood pressure and heart rate; strength; and capacity for physical activity? How does a program of exercise and activity influence the psychosocial health of people with behavioural diagnoses as it relates to measures of hope, depression, anxiety, and self-esteem? How does a program of exercise and activity influence occupational performance and satisfaction of people with a behavioural diagnoses? How does a program of exercise and activity influence quality of life for people with a behavioral diagnoses ? How does participating in a program of exercise and activity influence the overall perceptions of people with behavioural diagnoses? What is the feasibility and fidelity of this 14-week intervention? How does being part of a program of exercise and activity for people with behavioural diagnoses influence perceptions of rehabilitation sciences students about mental illness?
EXPERIMENTAL DESIGN:
This follow up study involves a group of up to ten past participants recruited from patients being treated by the OU-Tulsa IMPACT Team. We will conduct interviews and baseline measures to compare to past progress. This study will serve to inform future cohorts for the original study protocol.
PROPOSED PROCEDURE:
Assessments include biophysical markers of health, self-reported psychosocial measures, and records of exercise and activity. Specifically, we will measure:
Cholesterol, lipids, and glucose/ A1C via blood specimens collected as a routine part of the patient's care Height and weight via stadiometer and digital scale, abdominal girth (the narrowest point between the xiphoid process and the navel) using a Gulick tape measure.
Blood pressure using a sphygmomanometer & heart rate by counting the pulse for 60 seconds using a digital timer Cardiovascular endurance via the three-minute step test Depression via the PHQ9 scale Anxiety using the Generalized Anxiety Disorder Test Interview/Focus Group Mental Illness Clinician Attitude Scale (MICA) This brief follow up study will assess participants who are one year out from the program or more. The study will take place in their residence and include the measures stated above and an interview. Researchers want to understand how the program is beneficial after one year and what can be improved to maintain benefits if any. Findings will be used to adjust the original protocol if needed to continue the original study. The assessments and interviews will be completed by researchers and occupational and physical therapy students under the supervision of their faculty. In addition, participants will be offered educational materials to help resume healthy habits.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oklahoma
-
Tulsa, Oklahoma, United States, 74135
- University of Oklahoma Health Sciences Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
All study participants will be over the age of 21 and will include women and likely some individuals who report minority status with a mental health diagnosis
Exclusion Criteria:
Under the age of 21 or who are not psychologically stable in the last month
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Single Group Pilot study pre/post
One group of 8 participants receiving 14 week intervention
|
Integrating Healthy Habits Optimized by Community Participation and Engagled Learning
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Canadian Occupational Performance Measure
Time Frame: pre and post 14 week intervention
|
self-rating goal tool
|
pre and post 14 week intervention
|
|
Coach Fidelity Log Sheet
Time Frame: first 8 weeks
|
Coaches collected data for consistency of intervention
|
first 8 weeks
|
|
PHQ-9
Time Frame: week1 and week 14
|
self-rating depression screener
|
week1 and week 14
|
|
GAD
Time Frame: week1 and week 14
|
Self-rated anxiety scale
|
week1 and week 14
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood Lipids
Time Frame: week1 and week 14
|
hemoglobin, cholesterol, lipids, insulin, glucose, triglycerides, high-density lipoproteins;
|
week1 and week 14
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9088
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Severe Mental Illness
-
Shalvata Mental Health CenterActive, not recruitingSevere Mental IllnessIsrael
-
King's College LondonSouth London and Maudsley NHS Foundation TrustCompletedSevere Mental IllnessUnited Kingdom
-
Education University of Hong KongBaptist Oi Kwan Social ServiceCompletedSevere Mental IllnessHong Kong
-
New York UniversityUniversity of Pennsylvania; Yale UniversityCompleted
-
Oulu University HospitalUniversity of OuluRecruiting
-
University of GroningenLentis Psychiatric Institute; GGZ Friesland; Stichting CosisRecruitingSevere Mental IllnessNetherlands
-
Shalvata Mental Health CenterRecruitingSevere Mental IllnessIsrael
-
Indiana UniversityCompleted
-
The Royal Ottawa Mental Health CentreNot yet recruiting
-
GGZ CentraalZonMw: The Netherlands Organisation for Health Research and DevelopmentNot yet recruitingLifestyle | Severe Mental IllnessNetherlands
Clinical Trials on IHOPE
-
Boston Medical CenterWithdrawnAnxiety | Advanced Cancer | Depression Chronic